CELH
Celsius Holdings, Inc.
CELH has the edge over PRDO overall, supported by stronger valuation and stronger modeled upside.
PRDO
Perdoceo Education Corporation
PRDO has lower modeled downside risk, despite its lower overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
PRDO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Strong |
PRDO's profitability, cash flow and balance sheet are currently strong, and its revenue is stable.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH has the edge over PRDO in the historical PE scenario, which offers more potential upside but is not a forecast.
PRDO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.1x | $20.16 | -31% |
| Fair | 9.4x | $26.91 | -7.6% |
| Current | 10x | $29.13 | — |
| Expensive | 14x | $39.30 | +35% |
Historical ranges are pointers, not guarantees.
PRDO's PE is in its fair range at 10x.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
PRDO Forward outlook
There aren't enough analyst estimates for PRDO to show an outlook.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
PRDO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.85 | +22% |
| Q2 2026 | $2.75 | +20% |
| Q1 2026 | $2.62 | +16% |
| Q4 2025 | $2.42 | +11% |
| Q3 2025 | $2.33 | +17% |
| Q2 2025 | $2.30 | +13% |
| Q1 2025 | $2.25 | -0.9% |
| Q4 2024 | $2.19 | +0.5% |
PRDO has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH's revenue has grown year over year for six quarters in a row: $847M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH's operating margin was 20% last quarter, up 31 points from the same quarter a year ago.
PRDO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $215.9M | +1.9% |
| Q2 2026 | $213.4M | +1.8% |
| Q1 2026 | $221.7M | +4.1% |
| Q4 2025 | $211.6M | +20% |
| Q3 2025 | $211.9M | +25% |
| Q2 2025 | $209.6M | +26% |
| Q1 2025 | $213M | +27% |
| Q4 2024 | $176.4M | +19% |
PRDO's revenue has grown year over year for eight quarters in a row: $216M last quarter, up 1.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 26% | +1.5 points |
| Q2 2026 | 26% | +1.2 points |
| Q1 2026 | 28% | +4.2 points |
| Q4 2025 | 20% | -1.3 points |
| Q3 2025 | 24% | -2.3 points |
| Q2 2025 | 25% | -3.1 points |
| Q1 2025 | 24% | -3.2 points |
| Q4 2024 | 21% | +10 points |
PRDO has the edge over CELH on profitability, with a higher operating margin.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
PRDO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $77.6M | +97% |
| Q2 2026 | $73.1M | -3.9% |
| Q1 2026 | $67.6M | +6.7% |
| Q4 2025 | $37.9M | +137% |
| Q3 2025 | $39.4M | -21% |
| Q2 2025 | $76M | +102% |
| Q1 2025 | $63.4M | +19% |
| Q4 2024 | $16M | +38% |
PRDO has the edge over CELH on cash flow, with more consistent year-over-year improvement.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has 255M diluted shares, down 1.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
PRDO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.5% | -337K shares |
| 1 year | -4.2% | -2.8M shares |
| 3 years | -5.7% | -3.9M shares |
| 5 years | -11% | -8.2M shares |
| Available history | -12% | -8.8M shares |
PRDO has the edge over CELH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.9M |
| Q2 2026 | $6.8M |
| Q1 2026 | $8.1M |
| Q4 2025 | $54.1M |
| Q3 2025 | $20.6M |
| Q2 2025 | $20.9M |
| Q1 2025 | $25.2M |
| Q4 2024 | — |
PRDO spent $89M buying back its own shares over the past year, up 33% from the year before.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
PRDO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
| Q4 2025 | -0.5x | Net Cash |
| Q3 2025 | -0.7x | Net Cash |
| Q2 2025 | -0.8x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -0.6x | Net Cash |
PRDO has the edge over CELH on leverage, with a lower net debt burden relative to earnings.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
PRDO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.5 | Neutral |
| Stochastic | 16.3 | Oversold |
PRDO's weekly RSI is 42 (neutral) and its Stochastic is 16 (oversold).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
PRDO PE vs Consumer Defensive Sector
| Metric | PRDO | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 19x | 48% below |
| PE % | 55 | 18 | 37 pts above |
PRDO has the edge over CELH on valuation relative to its sector.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has the edge over PRDO on trend strength, trading above more of its moving averages.
PRDO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 6.6% below |
| 20 week MA | $32.2 | 9.6% below |
| 50 week MA | $32.7 | 11% below |
| 100 week MA | $31.3 | 7% below |
| 200 week MA | $24.7 | 18% above |
PRDO has fallen below most of its moving averages, though it's still 18% above its 200-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
PRDO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $18.5 | $13.1 | -29% |
| 2021 | $13.1 | $11.6 | -11% |
| 2022 | $11.6 | $14.1 | +21% |
| 2023 | $14.1 | $17.6 | +25% |
| 2024 | $17.6 | $26.3 | +50% |
| 2025 | $26.3 | $29.8 | +13% |
| 2026 YTD | $29.8 | $29.1 | -2.1% |
PRDO has the edge over CELH on returns for 2026, with the stronger performance.